(Z)-[(4-Chlorophenyl)methyl][(4-nitrophenyl)methylidene]oxidoazanium

Catalog No.: 
ACQGMD676
CAS No.: 
939888-34-3
Molecular Formula: 
C14H11ClN2O3
Molecular Weight: 
290.71
(Z)-[(4-Chlorophenyl)methyl][(4-nitrophenyl)methylidene]oxidoazanium structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
250mg90%$98.00InquiryInquiry
1g90%$291.00InquiryInquiry
5g90%$1426.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name(Z)-[(4-Chlorophenyl)methyl][(4-nitrophenyl)methylidene]oxidoazanium
IUPAC Name(Z)-N-(4-chlorobenzyl)-1-(4-nitrophenyl)methanimine oxide
MDL No.MFCD09757709
Molecular FormulaC14H11ClN2O3
Molecular Weight290.71
SMILES[O-]/[N+](CC1=CC=C(Cl)C=C1)=C\C2=CC=C([N+]([O-])=O)C=C2
InChI KeyFUKFGIOTXSAADA-YBEGLDIGSA-N
Synonym(Z)-[(4-chlorophenyl)methyl][(4-nitrophenyl)methylidene]oxidoazanium;Benzenemethanamine, 4-chloro-N-[(4-nitrophenyl)methylene]-, N-oxide
CAS No.939888-34-3

Synthetic Route by SureRoute

1. ACQGMD676 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACJKEB498 route compound structure diagram
    ACJKEB498555-16-8In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACQGMD676 route product structure diagram
    ACQGMD676939888-34-3
Inquiry

2. ACQGMD676 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACJKEB498 route compound structure diagram
    ACJKEB498555-16-8In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACQGMD676 route product structure diagram
    ACQGMD676939888-34-3
Inquiry

3. ACQGMD676 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACQGMD676 route product structure diagram
    ACQGMD676939888-34-3
Inquiry

Comments (0)